Vishnu Chemicals
- P/E
- 24.04
Key Fundamentals
MicrocapChemicals & PetrochemicalsChemicalsPrice-based figures as of · EPS basis: Consolidated · TTM
- ROCE
- 16.40%
- Debt to Equity
- 0.49
- EPS (TTM)
- ₹22.24
- Book Value
- ₹170.37
- Market Cap
- —
- P/E (TTM)
- 24.04
- P/B
- 3.14
- ROE
- 14.30%
- Dividend Yield
- 0.06%
- EBITDA
- ₹275 Cr
- 52W High
- ₹744.00
- 52W Low
- ₹471.20
- Day Range
- ₹504.00 – ₹546.90
- Volume
- 90,226
Peer Comparison
Commodities › Chemicals › Specialty Chemicals
| ₹1,510.20 | 58.04 | ₹1,54,107 Cr | 13.72 | 1.42% | 23.90% | 31.00% | ₹15,399 Cr | ₹2,677 Cr | |
| ₹4,613.30 | 83.76 | ₹49,073 Cr | 6.04 | 0.07% | 7.82% | 9.64% | ₹5,303 Cr | ₹600 Cr | |
| ₹8,785.00 | 57.03 | ₹44,060 Cr | 10.10 | 0.09% | 19.60% | 21.00% | ₹3,634 Cr | ₹789 Cr | |
| ₹1,578.40 | 27.48 | ₹20,919 Cr | 3.32 | 0.49% | 9.82% | 11.40% | ₹8,575 Cr | ₹784 Cr | |
| ₹1,540.70 | 86.90 | ₹20,030 Cr | 7.88 | 0.00% | 9.66% | 11.90% | ₹1,231 Cr | ₹235 Cr | |
| ₹447.55 | 30.57 | ₹15,838 Cr | 2.59 | 0.23% | 7.13% | 6.86% | ₹9,010 Cr | ₹531 Cr | |
| ₹5,156.50 | 19.67 | ₹14,827 Cr | 2.31 | 0.59% | 11.50% | 14.90% | ₹6,969 Cr | ₹788 Cr | |
| ₹534.75 | 24.04 | ₹3,510 Cr | 3.14 | 0.06% | 14.30% | 16.40% | ₹1,696 Cr | ₹150 Cr | |
| Median 8 companies | ₹1,559.55 | 43.80 | ₹20,474 Cr | 4.68 | 0.16% | 10.66% | 13.40% | ₹6,136 Cr | ₹692 Cr |
Comparable companies in the same industry. Market cap, P/E and P/B use the latest price; other metrics are as reported in filings. A dash means the figure is not published for that company.
Tapetide Score
Data-driven rating, 0–100, as of . How it works →
Overall score
Data confidence 100/100
Category scores
- Quality
- 56
- Good
- Returns, margins, earnings quality 22% weight
- Valuation
- 27
- Poor
- Cheap vs sector & own history 24% weight
- Growth
- 67
- Strong
- Sales & profit trajectory 9% weight
- Financial Health
- 38
- Weak
- Solvency, leverage, coverage 9% weight
- Momentum
- 26
- Poor
- Trend strength, vol-adjusted 12% weight
- Ownership
- 39
- Weak
- FII/DII/promoter flows 24% weight
The Tapetide Score is data analysis, not investment advice. Tapetide is not a SEBI-registered research analyst or investment adviser.
Key Insights
No strengths listed
Weaknesses
1- Dividend payout has been low at 1.65% of profits over last 3 years
Technical Indicators
| Group | Signal | Bearish | Neutral | Bullish |
|---|---|---|---|---|
| Overall | Strong Bearish | 12 | 5 | 2 |
| Oscillators | Neutral | 2 | 5 | 2 |
| Moving Averages | Strong Bearish | 10 | 0 | 0 |
Oscillators
Neutral
Overall
Strong Bearish
Moving Averages
Strong Bearish
Key readings
- RSI (14)
- 31.28
- Neutral
- MACD (12,26,9)
- −36.96
- Bearish
- SMA (50)
- 651.28
- Bearish
- SMA (200)
- 586.78
- Bearish
As of
Growth Rate
From the financial statements below. 10Y, 5Y, 3Y: compound annual growth to Mar 2026; 1Y: fiscal year to Mar 2026 against Mar 2025; TTM: four quarters to Jun 2026 against Jun 2025.
Revenue
| 10Y | +12.86% |
|---|---|
| 5Y | +18.85% |
| 3Y | +4.99% |
| 1Y | +11.26% |
| TTM | +16.49% |
Net profit
| 10Y | +21.06% |
|---|---|
| 5Y | +33.10% |
| 3Y | +1.20% |
| 1Y | +11.81% |
| TTM | +17.19% |
Operating cash flow
| 10Y | +12.53% |
|---|---|
| 5Y | +13.64% |
| 3Y | −1.77% |
| 1Y | +41.11% |
| TTM | — |
TTM: Reported once a year, so there is no trailing-twelve-month figure.
Operating margin· change in pp
| 10Y | −1.79 pp |
|---|---|
| 5Y | +4.08 pp |
| 3Y | −0.90 pp |
| 1Y | −0.12 pp |
| TTM | −0.28 pp |
Revenue by year
| Mar 2017 | ₹507 Cr |
|---|---|
| Mar 2018 | ₹643 Cr |
| Mar 2019 | ₹769 Cr |
| Mar 2020 | ₹674 Cr |
| Mar 2021 | ₹679 Cr |
| Mar 2022 | ₹1,069 Cr |
| Mar 2023 | ₹1,391 Cr |
| Mar 2024 | ₹1,213 Cr |
| Mar 2025 | ₹1,447 Cr |
| Mar 2026 | ₹1,610 Cr |
Net profit by year
| Mar 2017 | ₹7.00 Cr |
|---|---|
| Mar 2018 | ₹14.00 Cr |
| Mar 2019 | ₹24.00 Cr |
| Mar 2020 | ₹22.00 Cr |
| Mar 2021 | ₹34.00 Cr |
| Mar 2022 | ₹81.00 Cr |
| Mar 2023 | ₹137 Cr |
| Mar 2024 | ₹101 Cr |
| Mar 2025 | ₹127 Cr |
| Mar 2026 | ₹142 Cr |
AI Analysis — Bull vs Bear
Vishnu Chemicals Ltd is a mid-cap specialty chemicals company with a market cap of ₹4,184 Cr, trading at a P/E of 29.1x. The company controls approximately 60% of India's chromium chemicals market and 40% of the barium compounds market. While it has delivered a 5-year stock CAGR of 37% and 5-year profit CAGR of 33%, recent growth has moderated with 3-year sales CAGR at just 5% and 3-year profit CAGR at 2%.
- Dominant domestic market position with ~60% share in chromium chemicals and ~40% in barium compounds, providing strong pricing power
- Exceptional long-term wealth creation with 5-year stock CAGR of 37% and 10-year stock CAGR of 27%
- Strong 5-year compounded profit growth of 33% demonstrating operating leverage over a full cycle
- Strategic acquisition of a chrome ore mine with >10 million metric tonnes of reserves, providing 30-50 years of raw material security and potential margin improvement
- Diversified customer base with 170+ global customers, top customer contributing only ~5% of revenues, reducing concentration risk
- Balanced domestic (52%) and export (48%) revenue mix offering geographic diversification
- Capacity utilization at ~80% across both chromium and barium segments, with room to grow volumes without major capex
- 10-year compounded sales CAGR of 13% and profit CAGR of 21% indicate consistent long-term compounding ability
- Significant growth slowdown with 3-year sales CAGR of only 5% and 3-year profit CAGR of just 2%, well below long-term averages
- Promoter holding has decreased by 5.79% over the last 3 years, signaling potential lack of confidence or need for liquidity
- Negligible dividend payout at just 1.65% of profits over the last 3 years with a dividend yield of only 0.05%, offering almost no income return
- ROE has declined from 5-year average of 20% to 14% in the last year, indicating deteriorating return efficiency
- P/E of 29.1x is elevated for a commodity chemicals business that has delivered only 2% profit CAGR over 3 years
- P/B ratio of 3.88x is premium for a capital-intensive chemicals manufacturer with cyclical earnings
- Chromium chemicals market globally growing at only ~4.9% CAGR, limiting structural growth tailwinds
- TTM sales growth of 11% and profit growth of 12% are moderate and may not justify the current valuation multiple
This is AI-generated analysis, not financial advice. Do your own due diligence.
AI News Digest
TL;DR: No negative catalysts in the recent news flow for Vishnu Chemicals. The company is maintaining routine corporate governance with a recommended dividend and scheduled AGM. Active investor engagement via an upcoming earnings call and analyst meet signals management openness. The near-term focus shifts to Q1FY27 results on August 3, which will set the tone for the stock.
- Final dividend recommended for FY26 Jul 24
Board recommends a final dividend for FY25-26. Record date fixed as August 21, 2026, with 33rd AGM scheduled for August 28.
- Q1FY27 earnings call Aug 3 Jul 27
Vishnu Chemicals will host its Q1FY27 analysts' conference call on August 3, 2026 at 11 AM featuring key management executives. No financial metrics disclosed yet.
- Analyst meet at Emkay Confluence Jul 29
Company will participate in Emkay Confluence 2026 in Mumbai on August 12 with one-on-one and group discussions from 12 PM to 6 PM.
- AGM and e-voting schedule set Jul 24
33rd AGM scheduled for August 28, 2026. Remote e-voting window runs August 25-27 for shareholders.
Quarterly Results
₹ Cr| Particulars | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | Sep 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 301 | 308 | 304 | 300 | 339 | 344 | 371 | 393 | 347 | 401 | 411 | 450 | 433 | 430 |
| Expenses | 250 | 262 | 263 | 237 | 283 | 299 | 308 | 329 | 291 | 343 | 350 | 374 | 368 | 366 |
| Operating Profit | 51 | 46 | 41 | 64 | 56 | 45 | 64 | 64 | 56 | 58 | 62 | 77 | 65 | — |
| OPM % | 17% | 15% | 13% | 21% | 16% | 13% | 17% | 16% | 16% | 15% | 15% | 17% | 15% | — |
| Other Income | 2 | 3 | 4 | 3 | 3 | 4 | 3 | 6 | 5 | 9 | 6 | 2 | 13 | 10 |
| Interest | 9 | 9 | 9 | 9 | 9 | 10 | 10 | 8 | 8 | 12 | 14 | 5 | 12 | 14 |
| Depreciation | 7 | 9 | 9 | 9 | 9 | 9 | 12 | 8 | 10 | 10 | 11 | 10 | 11 | 11 |
| PBT | 37 | 31 | 27 | 49 | 40 | 30 | 44 | 53 | 42 | 46 | 44 | 64 | 55 | 48 |
| Tax % | 23% | 22% | 23% | 43% | 24% | 25% | 23% | 27% | 23% | 28% | 23% | 32% | 28% | 27% |
| Net Profit | 29 | 24 | 21 | 28 | 30 | 23 | 34 | 39 | 32 | 33 | 34 | 43 | 40 | 36 |
| EPS (₹) | 4.79 | 3.66 | 3.17 | 4.23 | 4.65 | 3.49 | 5.25 | 5.78 | 4.79 | 4.88 | 5.02 | 6.45 | 5.89 | — |
Sep 2026: from the results filed on 31 Oct 2026, ahead of the full statement, so some rows are blank.
Profit & Loss
₹ Cr| Particulars | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 418 | 480 | 507 | 643 | 769 | 674 | 679 | 1,069 | 1,391 | 1,213 | 1,447 | 1,610 | 1,696 |
| Expenses | 339 | 396 | 441 | 562 | 667 | 591 | 600 | 911 | 1,160 | 1,010 | 1,217 | 1,356 | 1,434 |
| Operating Profit | 79 | 84 | 66 | 81 | 102 | 82 | 79 | 158 | 231 | 202 | 229 | 253 | 262 |
| OPM % | 19% | 18% | 13% | 13% | 13% | 12% | 12% | 15% | 17% | 17% | 16% | 16% | 15% |
| Other Income | 1 | 2 | 7 | 8 | 3 | 7 | 3 | 6 | 15 | 12 | 15 | 23 | 31 |
| Interest | 34 | 37 | 44 | 49 | 47 | 39 | 27 | 28 | 35 | 37 | 37.3 | 38.36 | 42 |
| Depreciation | 12 | 13 | 16 | 19 | 21 | 20 | 20 | 23 | 26 | 34 | 38 | 41 | 42 |
| PBT | 34 | 36 | 14 | 22 | 37 | 30 | 34 | 112 | 185 | 144 | 168 | 195 | 209 |
| Tax % | 36% | 41% | 52% | 35% | 35% | 27% | −1% | 28% | 26% | 30% | 25% | 27% | — |
| Net Profit | 22 | 21 | 7 | 14 | 24 | 22 | 34 | 81 | 137 | 101 | 127 | 142 | 150 |
| EPS (₹) | 3.66 | 3.56 | 1.1 | 2.42 | 4.08 | 3.72 | 5.78 | 13.63 | 22.86 | 15.43 | 18.81 | 21.13 | 22.24 |
| Div. Payout % | 11% | 6% | 0% | 8% | 5% | 5% | 3% | 3% | 2% | 2% | 2% | 1% | — |
Balance Sheet
₹ Cr| Particulars | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 12 | 12 | 12 | 12 | 12 | 12 | 12 | 12 | 12 | 13 | 13 | 13 |
| Reserves | 79 | 106 | 85 | 99 | 130 | 148 | 184 | 265 | 402 | 688 | 913 | 1,056 |
| Borrowings | 225 | 263 | 322 | 381 | 348 | 328 | 336 | 365 | 379 | 315 | 342 | 527 |
| Other Liabilities | 177 | 239 | 275 | 289 | 266 | 247 | 242 | 274 | 258 | 310 | 366 | 493 |
| Total Liabilities | 492 | 620 | 694 | 782 | 757 | 736 | 773 | 916 | 1,052 | 1,326 | 1,635 | 2,089 |
| Fixed Assets | 186 | 202 | 290 | 349 | 350 | 338 | 387 | 463 | 465 | 635 | 702 | 836 |
| CWIP | 44 | 66 | 62 | 17 | 19 | 36 | 24 | 5 | 98 | 16 | 69 | 159 |
| Investments | 0 | 0 | 1 | 2 | 1 | 1 | 1 | 3 | 2 | 2 | 0 | 1 |
| Other Assets | 262 | 352 | 342 | 415 | 387 | 360 | 361 | 444 | 488 | 675 | 864 | 1,094 |
| Total Assets | 492 | 620 | 694 | 782 | 757 | 736 | 773 | 916 | 1,052 | 1,326 | 1,635 | 2,089 |
Cash Flow
₹ Cr| Particulars | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating | 13 | 39 | 73 | 89 | 100 | 49 | 67 | 90 | 134 | 68 | 90 | 127 |
| Investing | −9 | −43 | −98 | −33 | −23 | −22 | −52 | −81 | −118 | −154 | −100 | −267 |
| Financing | 1 | 4 | 25 | −56 | −78 | −24 | −19 | −9 | −16 | 88 | 10 | 146 |
| Net Cash Flow | 5 | −1 | 0 | 0 | −1 | 4 | −4 | 0 | 0 | 2 | 0 | 5 |
| Free Cash Flow | 3 | −5 | −26 | 56 | 75 | 23 | 13 | 8 | 19 | −53 | 2 | −130 |
| CFO/OP | 22 | 55 | 111 | 121 | 109 | 74 | 94 | 64 | 79 | 48 | 57 | 65 |
Ratios
| Particulars | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 78 | 88 | 69 | 82 | 64 | 49 | 62 | 65 | 47 | 69 | 74 | 70 |
| Inventory Days | 230 | 314 | 269 | 212 | 201 | 252 | 243 | 143 | 142 | 263 | 242 | 271 |
| Days Payable | 117 | 225 | 201 | 207 | 147 | 167 | 174 | 146 | 120 | 187 | 172 | 193 |
| Cash Conversion Cycle | 191 | 176 | 137 | 87 | 117 | 134 | 131 | 63 | 69 | 145 | 145 | 149 |
| Working Capital Days | 37 | 3 | −70 | −24 | −3 | 2 | 6 | 10 | 21 | 54 | 67 | 66 |
| ROCE % | — | 21% | 14% | 16% | 17% | 14% | 12% | 24% | 30% | 20% | 18% | 16% |
Insights
BetaAI-extracted from concalls & annual reports · figures as reported, with sources
Log in to view Vishnu Chemicals insights
69 extracted metrics across FY10–FY27.
Documents
- Q1 FY27 concall · Aug 2026Transcript PPT
- Concall · Jun 2026PPT
- Q3 FY26 concall · Feb 2026Transcript PPT
- Q2 FY26 concall · Nov 2025PPT
- Q1 FY26 concall · Aug 2025Transcript PPT Recording
- 30 May 2026
- 21 Nov 2025
- 3 Jan 2025
- 27 Nov 2023
- 10 Feb 2023
- 29 Oct 2020
- Outcome 31 Oct 2026
- General announcements 31 Oct 2026
Frequently Asked Questions about Vishnu Chemicals
What does Vishnu Chemicals Ltd do?
Where is Vishnu Chemicals Ltd (VISHNU) listed?
Which sector does Vishnu Chemicals Ltd belong to?
What is the PE ratio of Vishnu Chemicals Ltd?
What is the 52-week high and low of Vishnu Chemicals Ltd?
Does Vishnu Chemicals Ltd pay dividends?
What is the Return on Equity (ROE) of Vishnu Chemicals Ltd?
Company Information
Incorporated in 1989, Vishnu Chemicals Limited is in the business of manufacturing, marketing and export of Chromium chemicals and Barium compounds across the world. Located in Hyderabad, the company is serving more than 12 industries across 57 countries globally.
For AI agents and developers
Reading this as an AI agent, LLM or automated pipeline? Every page on Tapetide is also published as clean Markdown — no navigation, no scripts, just the data. Fetch https://tapetide.com/stocks/VISHNU.md for Vishnu Chemicals Ltd: dated key facts, then this page's sections in order: latest price, key fundamentals, peer comparison, the Tapetide Score, technical indicators, analyst ratings, growth rates, analyst forecasts, the AI analysis and news digest (labelled as AI-generated), financial statements, shareholding pattern, documents and the FAQ.
Append .md to any Tapetide URL for
the same treatment. A full index of what we publish is at /llms.txt and /llms-full.txt. For
live, structured queries instead of documents, use our Indian stock market MCP server.